Fluoroquinolone Black Box Will Include Stronger Warnings Of Muscle, Nerve Damage

(July 27, 2016, 12:14 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on July 26 strengthened the black box warning on fluoroquinolone antibiotics to warn that they are associated with disabling and potentially permanent side effects to the tendons, muscles, joints, nerves and the central nervous system.

Drugs in the fluoroquinolone class include Avelox, Cipro, Cipro extended release, Factive, Levaquin and Ofloxacin.

The FDA said fluoroquinolones should be reserved for use in patients who have no other treatment options for acute bacterial sinusitis, acute acerbation of chronic bronchitis and...
To view the full article, register now.